Direct factory sourcing from verified China cGMP manufacturing facilities
Understanding global demand, chemical synthesis advantages, and supplier selection for anti-obesity formulations
With global metabolic disorders and obesity rates escalating continuously, Orlistat remains the premier non-systemic, reversible pancreatic lipase inhibitor approved for over-the-counter (OTC 60mg) and prescription (Rx 120mg) weight management. Demand for high-quality finished dosage forms (FDF) has spiked across North America, Europe, LATAM, and Southeast Asia.
China leads global Orlistat raw material and finished capsule production due to fully integrated upstream chemical synthesis (derived from Lipstatin fermentation processes), specialized pellet extrusion technology, cost-efficient scale, and robust cGMP compliance infrastructure meeting US FDA and EU CEP regulatory standards.
Leading Chinese pharmaceutical manufacturers maintain strict adherence to international quality guidelines (ICH Q7, Q8, Q9, Q10). Facilities feature state-of-the-art HVAC cleanroom environments (Class 100,000 / ISO 8), zero-cross-contamination automated encapsulation lines, and real-time stability testing under Zone IVb climate conditions.
Orlistat (CAS Number: 96827-07-5, Molecular Formula: C29H53NO5) is a hydrogenated derivative of lipstatin, naturally produced by the bacterium Streptomyces toxytricini. Functioning strictly within the lumen of the stomach and small intestine, Orlistat forms a covalent bond with the active serine site of gastric and pancreatic lipases. By inactivating these enzymes, the body is rendered incapable of hydrolyzing dietary fat (triglycerides) into absorbable free fatty acids and monoglycerides. Approximately 30% of ingested dietary fat passes through the gastrointestinal tract unabsorbed, providing a proven therapeutic protocol for chronic weight management and glycemic control in diabetic patients.
E-E-A-T Technical Insight: Unlike systemic anti-obesity agents that cross the blood-brain barrier to suppress appetite, Orlistat exhibits less than 1% systemic absorption. Consequently, regulatory scrutiny focuses primarily on local dissolution profiles, pellet coating uniformity, impurity profiling (specifically Impurity A, B, C under Ph. Eur.), and batch-to-batch content uniformity in solid oral dosage forms.
When evaluating Chinese Orlistat capsule manufacturers, global buyers must assess technical parameter matrices to ensure compliance with USP, BP, and Ph. Eur. pharmacopeial monographs:
| Specification Parameter | USP / Ph. Eur. Standard | Typical Chinese Export Grade | Analytical Method |
|---|---|---|---|
| Active Ingredient Purity (API) | 98.0% - 101.5% | 99.2% - 100.8% | HPLC (High-Performance Liquid Chromatography) |
| Dosage Strength | 60 mg (OTC) / 120 mg (Rx) | Customized (60mg, 120mg, micro-pellets) | Assay by UV / HPLC |
| Dissolution Profile | NLT 75% (Q) in 45 mins | > 85% in 30 mins (Enhanced Bioavailability) | Dissolution Apparatus II (Paddle, 75 rpm) |
| Individual Impurities | NMT 0.2% | NMT 0.1% (Ultra-pure formulation) | Related Substances by HPLC |
| Residual Solvents | Meets ICH Q3C Requirements | Conforms to strict ICH boundaries | Headspace GC-MS |
| Water Content (Karl Fischer) | NMT 0.5% | NMT 0.3% | Volumetric Karl Fischer Titration |
Empowering pharmaceutical importers, distributors, and pharmacy chains worldwide with turnkey finished product solutions.
Navigating complex regulatory frameworks with end-to-end dossier assistance and regional distribution setup
We provide comprehensive Common Technical Documents (eCTD Format) covering Modules 1 through 5, including Drug Master Files (DMF), Certificates of Suitability (CEP), Process Validation Protocols, and Real-Time / Accelerated Stability Data under ICH climate zones I-IV.
To bridge timezone, cultural, and logistics barriers, specialized field representatives and local support teams are established in strategic hubs such as Mexico and South Africa, providing fast turnaround times for customs clearing, local registration, and inventory dispatch.
Complete OEM/ODM private label customization: ALU-ALU blister packaging, PVC/PVDC blister packs, high-density polyethylene (HDPE) bottles, anti-counterfeiting holographic seal integration, and localized multi-lingual packaging compliant with destination health authority laws.
The economic and technical moat of Chinese Orlistat capsule manufacturers lies in advanced chemical synthesis routes. Traditional Orlistat production relied heavily on natural extraction or multi-step total organic synthesis, leading to exorbitant costs and inconsistent batch yields. Contemporary Chinese bio-pharmaceutical complexes utilize a hybrid fermentation-chemical process:
Leading supply chain integration, technical consultation, API delivery, and turn-key laboratory engineering
An overall factory construction area of 250,000 square meters under international standards offers flexible, scalable, and cost-effective solutions for global pharmaceutical, industrial chemical, and biological developers.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standards from long-term collaborations. Regulatory documents and certificates (COA, MSDS, DMF) are backed by robust support for clients worldwide.
For clients who prefer to avoid the complexity of dealing with multiple points of contact, Gentolex provides extra customized procurement services leveraging superior, highly integrated chemical supply chain networks.
Gentolex Corporate Vision: Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specifically establishing active local representatives in Mexico and South Africa. Our core service spectrum includes supplying Peptide APIs, Custom Peptides synthesis, Finished Dosage Form (FDF) license out, Technical Support & Consultation, Product Line and Lab Setup, and Sourcing & Supply Chain Solutions.
Explore technical whitepapers on high-purity research peptides, neuroactive compounds, and mitochondrial targeting agents
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a synthetic derivative of the endogenous tetrapeptide tuftsin, modified to extend metabolic half-life while retaining potent neuroprotective properties.
As a professional Thymosin Beta-4 API manufacturer and supplier, we deliver ultra-high purity Tβ4 peptide API solutions for bio-technology firms, pharmaceutical clinical trials, and life-science research organizations focused on tissue repair, cellular migration, and inflammatory cascade modulation.
BPC-157 API is a synthetic pentadecapeptide that has gained widespread attention in peptide therapeutics due to its biological activities related to gastrointestinal protection, muscle-tendon healing, and angiogenesis regulation, manufactured under strict peptide synthesis protocols.
Derived from an ACTH fragment, Semax has attracted international scientific interest due to its molecular interactions with neurotrophic factors (BDNF). Our cGMP production infrastructure ensures batch-to-batch consistency for neuro-pharmacological investigation.
SS-31 API (Elamipretide, MTP-131, Bendavia) is a synthetic mitochondria-targeting tetrapeptide engineered to bind selectively to cardiolipin within the inner mitochondrial membrane. By stabilizing mitochondrial cristae structure and optimizing cellular bioenergetics, SS-31 represents a breakthrough target in metabolic and age-related therapeutic pipelines.
Addressing key commercial, technical, regulatory, and quality control queries for global buyers
High-purity chemical APIs and custom synthesized biological building blocks
